Published on: July 12, 2019 at 09:30PM
Conditions: Insulin Resistance - Type A; Insulin Resistance - Type B; Lipoatrophic Diabetes Mellitus; Insulin Resistance Syndrome
Intervention: Drug: Empagliflozin Tablets
Sponsors: Kobe University; Boehringer Ingelheim
Not yet recruiting
https://ift.tt/32oE5Ig
Friday, 12 July 2019
New diabetes clinical trial: A Multi-center Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.